The Technical Analyst
Select Language :
Deciphera Pharmaceuticals [DCPH]

Exchange: Nasdaq Global Select Sector: Healthcare Industry: Biotechnology

Deciphera Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Deciphera Pharmaceuticals is listed at the NASDAQ Exchange

3.69% $10.69

Last updated: 16 May 2022 @ 10:51 am


FUNDAMENTALS
MarketCap: 707.85 mill
EPS: -5.16
P/E: 0.000
Earnings Date: Aug 01, 2022
SharesOutstanding: 66.22 mill
Avg Daily Volume: 1.333 mill
RATING 2022-05-13
B+
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profit
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$12.25
(14.60%) $1.561
Date: 2022-05-16
True Range Average
+/- $0.787
( +/- 7.63%)
Range: 9.52 - 11.10
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-04-29 Brightstar Associates Llc Buy 3 389 830 Warrants (right to buy)
2022-04-29 Brightstar Associates Llc Buy 1 478 978 Common Stock
2022-03-21 Hoerter Steven L. Sell 3 150 Common Stock
2022-02-16 Pitman Jama Sell 1 146 Common Stock
2022-02-16 Kelly Thomas Patrick Sell 1 368 Common Stock
INSIDER POWER
82.31
Last 100 transactions
Buy: 6 408 857 | Sell: 782 611

Forecast: 12:30 - $10.71

Live Trading Signals (every 1 min)

Forecast 1: 11:00 - $10.67
Forecast 2: 11:50 - $10.81
Forecast 3: 12:30 - $10.71
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $10.69 (3.69% )
Volume 0.108 mill
Avg. Vol. 1.333 mill
% of Avg. Vol 8.11 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Deciphera Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Deciphera Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Deciphera Pharmaceuticals Inc

Last 10 Buy & Sell Signals For DCPH

320 Signals | Accuracy: 21.56% | Accuracy Buy: 23.75% | Accuracy Sell: 19.38%

Avg return buy: -0.08 % | Avg return sell: 0.11 %

$1 invested is now $0.87 or -12.60% since 20-04-22

Date Signal @ Closed %
May 16 - 10:42sell$10.68$10.70 @ May 16 - 10:490.23%
May 16 - 10:38buy$10.70$10.68 @ May 16 - 10:40-0.19%
May 16 - 10:37sell$10.69$10.70 @ May 16 - 10:380.09%
May 16 - 10:04buy$10.33$10.68 @ May 16 - 10:353.39%
May 16 - 09:31sell$10.24$10.33 @ May 16 - 10:030.88%
May 13 - 15:55buy$10.29$10.24 @ May 16 - 09:30-0.49%
May 13 - 15:35sell$10.30$10.29 @ May 13 - 15:55-0.10%
May 13 - 15:03buy$10.28$10.30 @ May 13 - 15:350.19%
May 13 - 13:56sell$10.31$10.28 @ May 13 - 15:02-0.29%
May 13 - 13:24buy$10.24$10.29 @ May 13 - 13:520.49%
The Live Chart for Deciphera Pharmaceuticals Inc
Profile picture for
            Deciphera Pharmaceuticals Inc

DCPH

Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of various cancer therapies. Its lead drug candidate is ripretinib for the treatment of gastrointestinal stromal tumors; and that is in Phase I trial for treating gliomas, melanoma, NSCLC/germ cell/penile, and soft tissue sarcomas. The company is also developing immunokinase inhibitors comprising DCC-3014 that is in Phase I trial for the treatment of tenosynovial giant cell tumors; and Rebastinib, which is in Phase Ib/II trial to treat solid tumors, as well as to investigate in combination with chemotherapy for the treatment of multiple solid tumors. In addition, its preclinical stage drug candidate is DCC-3116 for the treatment of RAS mutant cancers. Deciphera has partnership with K2fly, which offers cloud monitoring platform, to create an integrated monitoring and governance platform for tailing storage facilities. The company was founded in 2003 and is headquartered in Waltham, Massachusetts.

Last 10 Buy Signals
Date Signal @
WATTMay 16 - 10:49$0.924
VMBSMay 16 - 10:49$48.42
TPICMay 16 - 10:49$12.48
SVRAMay 16 - 10:49$1.285
SAVAMay 16 - 10:49$20.86
SEEDMay 16 - 10:49CNY7.78
SEACMay 16 - 10:49$0.837
SGENMay 16 - 10:49$143.26
RILYZMay 16 - 10:49$22.03
RIBTMay 16 - 10:48$0.610

Stock Peers

Company Price Change
DCPH10.693.69%
BLUE3.50-1.87%
DRNA38.220.00%
KYMR16.77-3.84%
MCRB3.78-0.26%
MGNX4.252.16%
NGM12.807.47%
PRLD4.640.43%
QTRX18.52-1.44%
RVNC14.705.91%
SRNE1.4702.80%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.